Northwest Biotherapeutics (NWBO) EBITDA Margin (2009 - 2026)
Northwest Biotherapeutics' EBITDA Margin came in at -1326.64% for Q2 2026, up 9210.00 percentage points from -10536.64% a year earlier and up 667.69 percentage points from the prior quarter.
Northwest Biotherapeutics (NWBO) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Northwest Biotherapeutics reported EBITDA Margin of -2124.94%, up 3483.38 percentage points year-over-year; for FY2025, it was -4061.18%, up 445.92 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +2407.07 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -4507.09% in FY2024 (-1835.71 pp), -2671.38% in FY2023 (+1081.33 pp), -3752.70% in FY2022 (+1230.08 pp) and -4982.79% in FY2021 (+1485.46 pp).
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q1 2020.
- Year-over-year, EBITDA Margin has increased for three consecutive quarters, with an average year-over-year change of +365.36 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2021 (a gain of 18992.41 percentage points), and the weakest in Q2 2025 (a drop of 7293.70 percentage points).
- Business Quant data shows NWBO's EBITDA Margin at -1994.33% (Q1 2026), -1809.82% (Q4 2025) and -6727.50% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Northwest Biotherapeutics | 283.78 Mn | 273.80 Mn | - | -1,326.64% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,326.64% |
| Mar 31, 2026 | -1,994.33% |
| Dec 31, 2025 | -1,809.82% |
| Sep 30, 2025 | -6,727.50% |
| Jun 30, 2025 | -10,536.64% |
| Mar 31, 2025 | -4,411.47% |
| Dec 31, 2024 | -7,447.62% |
| Sep 30, 2024 | -3,866.95% |
| Jun 30, 2024 | -3,242.94% |
| Mar 31, 2024 | -5,190.14% |
| Dec 31, 2023 | -3,225.17% |
| Sep 30, 2023 | -3,122.91% |
| Jun 30, 2023 | -6,220.40% |
| Mar 31, 2023 | -1,372.39% |
| Dec 31, 2022 | -2,881.07% |
| Sep 30, 2022 | -7,138.83% |
| Jun 30, 2022 | -4,166.67% |
| Mar 31, 2022 | -2,823.08% |
| Sep 30, 2021 | -2,740.00% |
| Jun 30, 2021 | -2,908.41% |
Northwest Biotherapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();